L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) signale de fortes tensions d\u2019approvisionnement sur les m\u00e9dicaments \u00e0 base de furos\u00e9mide en comprim\u00e9s de 20 mg et 40 mg en France, en lien avec des difficult\u00e9s de production rencontr\u00e9es par les laboratoires Viatris et Zentiva. Le furos\u00e9mide, diur\u00e9tique utilis\u00e9 notamment dans le traitement de l\u2019hypertension art\u00e9rielle et des \u0153d\u00e8mes li\u00e9s \u00e0 une insuffisance cardiaque, h\u00e9patique ou r\u00e9nale, fait l\u2019objet de perturbations d\u2019approvisionnement dont la normalisation n\u2019est pas attendue avant avril 2027 pour les sp\u00e9cialit\u00e9s de Viatris. Les autres laboratoires commercialisant du furos\u00e9mide compensent d\u00e9j\u00e0 depuis plusieurs mois le d\u00e9faut d\u2019approvisionnement de Viatris. Parall\u00e8lement, Zentiva fait \u00e9tat de difficult\u00e9s temporaires de production, sans date de remise \u00e0 disposition connue \u00e0 ce stade.<\/p>\n
Pour limiter l\u2019impact de ces tensions sur la continuit\u00e9 des traitements, l\u2019ANSM met en \u0153uvre plusieurs mesures. Elle demande aux autres laboratoires de lib\u00e9rer le maximum de bo\u00eetes en utilisant leurs stocks de s\u00e9curit\u00e9 et de restreindre les ventes directes aux pharmacies au profit du circuit des grossistes-r\u00e9partiteurs, afin d\u2019assurer une r\u00e9partition plus \u00e9quitable sur le territoire. Elle leur demande \u00e9galement d\u2019identifier des pistes d\u2019importation de m\u00e9dicaments \u00e9quivalents. L\u2019ANSM invite en outre les prescripteurs \u00e0 limiter les initiations de traitement par furos\u00e9mide et \u00e0 r\u00e9\u00e9valuer, lors du renouvellement des ordonnances, la pertinence de la poursuite du traitement, en privil\u00e9giant, lorsque la situation clinique le permet, un autre diur\u00e9tique.<\/p>\n
L\u2019ANSM indique que de nouvelles mesures pourront \u00eatre d\u00e9cid\u00e9es en fonction de l\u2019\u00e9volution de la situation. Les informations relatives aux dates de remise \u00e0 disposition seront actualis\u00e9es sur son site d\u00e8s communication par les industriels. Cette situation implique une vigilance particuli\u00e8re pour la prise en charge des patients souffrant d\u2019hypertension ou d\u2019insuffisance cardiaque, h\u00e9patique ou r\u00e9nale, et appelle un suivi rapproch\u00e9 de l\u2019impact potentiel de ces tensions sur l\u2019acc\u00e8s aux soins et l\u2019organisation des prescriptions.\u00a0(contenu r\u00e9sum\u00e9 par l’IA)Lire la Suite<\/a>\u200b<\/p>","protected":false},"excerpt":{"rendered":" L\u2019Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM) signale de fortes tensions d\u2019approvisionnement sur les m\u00e9dicaments \u00e0 base de furos\u00e9mide en comprim\u00e9s de 20 mg et […]<\/p>\n","protected":false},"author":1,"featured_media":3852,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[7],"tags":[63,227],"class_list":["post-20014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicaments-et-produits-de-sante","tag-ansm","tag-ia"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20014"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/20014\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/3852"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}